ArticleJournal of clinical medicine2026

Real-World Effectiveness of Polymerized House-Dust-Mite Subcutaneous Immunotherapy up to 24 Months: Why Baseline Symptom Severity Shapes Measurement of the Combined Symptom-Medication Response.

Margarita Rosa Acevedo Matos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.